Project Progress
Follow the project deliverables and delivery of the milestones
Last updated: 15-03-2024
Project duration
January 1, 2020 - December 31, 2024
Milestones
Milestones reached
Deliverables
Deliverables reached
- WP leader: Wim Van Bortel
- Country & Institution: Belgium, Institute of Tropical Medicine, Antwerp
- E mail: wvanbortel@itg.be
- Short description: WP1 evaluates user needs, establishes and maintains communication between the project and end-users during the project lifetime, and ensures data flow and usability of the project outputs for different international, European and national PH/VA agencies (especially in link with WP4 and WP5). It maps and assesses the epidemic intelligence1 capacities in the European PH/VH agencies in order to better target the technical innovations with MOOD.Institute of Tropical Medicine, Antwerp
- WP leader: Annapaola Rizzoli
- Country & Institution: Italy, Fondazione Edmund Mach
- E mail: annapaola.rizzoli@fmach.it
- Short description: WP2 creates detailed disease profiles to provide indicators, proxies and define “signals” of disease emergence. It also provides data (favouring open/free data sources, both indicator and event-based1) for WP3 and WP4 and ensures that outputs are realistic, pertinent, and useful about the state of knowledge on disease by creating a community of disease experts. Disease profiles and indicators will be set for major air-borne, vector-borne, food and water-borne infectious diseases, including an unknown disease (disease X) and antimicrobial resistance of interest to Europe.
- WP leader: Maguelonne Teisseire
- Country & Institution: France, Institut National de Recherche, pour l’Agriculture, l’Alimentation et l’Environnement
- E mail: maguelonne.teisseire@irstea.fr
- Short description: WP3 secures data pipelines that will extend beyond the duration of the project in link with WP2 and WP4. It starts from a core of existing data streams and data sets to ensure delivery, and add ad-hoc developments and innovations to ensure that data integration is adequate for modelling. It merges, standardises and uniformizes multi-source data for both outbreaks, climate and environmental change, vector distribution, movement of animals and passengers, next-gene sequence and antimicrobial resistance data.
- WP leader: Vittoria Colizza
- Country & Institution: France, Institut National de la Santé Et de la Recherche Médicale
- E mail: vittoria.colizza@inserm.fr
- Short description: WP4 analyses the disease indicators proposed by WP2 and in link with the needs of end-users in WP1. It develops disease-specific and generic methods for analysis and modelling to detect space – time anomalies, monitor diseases (endemic vs epidemic) and assess risk of disease emergence (importation and spread in Europe). It evaluates and adapt (in case of need) the models on the chosen disease systems according to the end-user needs (in link with WP1).
- WP leader: Cédric Marsboom
- Country & Institution: Belgium, AVIA-GIS
- E mail: cmarsboom@avia-gis.com
- Short description: WP5 develops sustainable open source tools based on the defined user needs (in link with WP1) and the models developed in WP4. It ensures piloting/demonstrating the platform and assessing/validating the results with end-users (in link with WP1) and fixing the platform based on the findings (in link with WP4). The tools will support both computer (web platform) and mobile (app) application so that they increase appropriation by a larger community of end-users.
- WP leader: Tomislav Hengl
- Country & Institution: Netherland, Stichting OpenGeoHub
- E mail: tom.hengl@opengeohub.org
- Short description: WP6 consolidates and follows up the MOOD tools in ecosystem with the end-users in the EU and beyond. It organizes local/EU events to improve policy and create a synergy with open source communities and public/private stakeholders to fuel sustainability of the innovations beyond the project duration. It closely monitors the change process (outcomes) for end-users to lift adoption of tools in risk assessment and decision-making (in link with WP1) in European PH/VH agencies and the PH/VH agencies in the neighbouring European third-countries.
- WP leader: Elena Arsevska
- Country & Institution: France, CIRAD, JRU ASTRE
- E mail: elena.arsevska@cirad.fr
- Short description: WP7 ensures that the project moves in conformity with the work plan with regard to milestones, deliverables, and planned resources. It implements a moderated process of interdisciplinary dialogue to ensure the workflow and communication between all WPs. In link with WP1 and WP6 ensures the monitoring and update of the innovation pathway of the project outcomes. This WP assures quality accomplishment of all activities by monitoring the risks and by respecting the ethics and data protection aspects of the project. It optimises the infrastructural setup to support the project in conformity to the EC rules and procedures.
- WP leader: Elena Arsevska
- Country & Institution: France CIRAD, JRU ASTRE
- E mail: elena.arsevska@cirad.fr
- Short description: WP8 sets out the “ethics requirements” that the project must comply with.
Completed Milestones
Total Milestones Completion Progress
46/53
86.79%
- M1 Identification of stakeholders
- M2 End-users needs survey
- M3 Participatory workshops
- M4 User stories translated into operational needs
- M5 State-of-the-art of epidemic intelligence systems
- M6 Disease X survey
- M7 Local stakeholders’ workshops
- M8 Tools co-conception participatory workshops
- M9 Social innovations’ participatory workshops
- M10 Strategy and prioritization of the data collection defined
- M11 Agreement with WP3 and WP4 on data requirement
- M12 Potential sources for genomic data collection identified
- M13 Selection of AMR pathogens completed
- M14 Systematic review protocol and searches strategy defined
- M15 Experts meeting planned
- M16 Covariate data requirements identified for each prototype pathogen and disease X
- M17 Intermediate delivery of systematic literature reviews results
- M18 Key words for automatic acquisition via web-scraping identified
- M19 Intermediate delivery of expert meetings results
- M20 Potential source of data identified and agreement on data use signed
- M21 Systematic literature reviews completed
- M22 Experts meetings completed
- M23 Model parameter values estimated
- M24 Data collection from AMR prevalence surveys in food animals completed
- M26 Interim progress report
- M27 Covariate data sources identified extraction and processing requirements established.
- M28 Covariate data supplied for modelling, on ad-hoc basis
- M29 Standardized covariate datasets produced
- M30 Design of the data integration chain
- M31 Implementation of the data integration chain
- M32 Design of the data linking chain
- M33 Implementation of the data linking chain
- M34 Standardised disease datasets
- M35 Linking patterns
- M36 Code implementation of SDMs modelling techniques
- M37 Availability of Bayesian phylodynamic inference tools
- M38 A pilot prototype of visual analytics on a selected data set
- M39 Approved System’s Architecture
- M40 MOOD online platform
- M41 Communication and dissemination channels
- M42 Business case
- M43 Exit strategy and restitution stakeholders’ workshop
- M44 Creation of partner database and internal collaborative platform
- M45 Organisation of kick-off and general assembly meetings
- M46 Set up of the Advisory Board
- M47 Creation and update of ethics management plan
- M48 Collection of the ethics approvals
- M49 Yearly advisory board assessment
- M50 Creation and update of data management plan
- M51 Collection of relevant data protection authorizations
- M52 Review of gender equality in partner institutes and in the research activities
- M53 Setting up indicators for monitoring the project process and outcomes
Completed Deliverables
WP1 Deliverables
WP2 Deliverables
WP3 Deliverables
WP4 Deliverables
WP5 Deliverables
WP6 Deliverables
WP7 Deliverables
WP8 Deliverables
WP1 Deliverables
- Deliverable 1.1 Report on user’s needs
- Deliverable 1.2 Strategy to take into account unknown diseases in Epidemic Intelligence systems
- Deliverable 1.3 Guidelines for consideration of local stakeholders’ engagement
- Deliverable 1.4 Report on learning loops fostering the utility of social and technical innovations
- Deliverable 1.5 Report on initial meetings with ECDC
WP2 Deliverables
- Deliverable 2.1 Scientific report on prototype pathogens and disease profiles
- Deliverable 2.2 Databases including all the data collected through the different sources including an open-access online repository for point prevalence
- Deliverable 2.3 Blueprints for epidemiological data collection and management
WP3 Deliverables
- Deliverable 3.1 Processing requirements, together with raw and processed covariate data
- Deliverable 3.2 Integration chain (processing algorithms and protocols) for disease datasets
- Deliverable 3.3 Linking chain (processing algorithms and protocols) for disease and covariate datasets
- Deliverable 3.4 Standardized datasets (covariate, disease data sets, and pattern linking)
WP4 Deliverables
- Deliverable 4.1 A prototype using visual analytics applied on a selected dataset from WP2
- Deliverable 4.2 Disease, vector and AMR risk maps
- Deliverable 4.3 Algorithm(s) for COVID-19 assessment integrating mobility
- Deliverable 4.4 Methods to infer phylodynamics patterns and transmission chains in WP4
- Deliverable 4.5 Assessment of COVID-19 policies for pandemic preparedness
- Deliverable 4.6 Model on circulation of drug resistant bacteria within Europe and between Europe and third countries
WP5 Deliverables
- Deliverable 5.1 MOOD System Architecture
- Deliverable 5.2 MOOD validation plan
- Deliverable 5.3 MOOD online platform
WP6 Deliverables
WP7 Deliverables
- Deliverable D7.1 Project Management Plan
- Deliverable D7.2 Quality Assurance Plan
- Deliverable D7.3 Risk register
- Deliverable D7.4 Data Management Plan (v1)
- Deliverable 7.5 Preliminary report on innovation and Impact pathway
- Deliverable 7.6 Report on the innovation and impact pathway
- Deliverable D7.8 Report on collaborative work plan and concrete actions between MOOD and VEO (v1.3)
- Deliverable 7.9 Report on 1st annual joint meeting of the leadership of both consortia (MOOD/VEO)
- Deliverable 7.10 Report on 2nd annual joint meeting of the leadership of both consortia (MOOD/VEO)
- Deliverable 7.11Report on 3rd annual joint meeting of the leadership of both consortia (MOOD/VEO)
- Deliverable 7.12 Report on 4th annual joint meeting of the leadership of both consortia (MOOD/VEO)
WP8 Deliverables
- Deliverable D8.1. H – Requirement No. 1- Informed consent form procedures
- Deliverable – D8.2. POPD – Requirement No. 2 – Data processed are relevant and limited of purposes
- Deliverable – D8.3 NEC – Requirement No. 3 – Activities in non-EU countries
- Deliverable D8.4 – Risk assessment measures to prevent stigmatization and misuse of research (M – Requirement No. 4)
- Deliverable D8.5 – GEN – Requirement No. 5 – MOOD Ethics and Data protection Advisory Board
- Deliverable D8.6 – GEN – Requirement No. 6 – Annual report Ethics/DP AB on ethics issues
- Deliverable D8.7 – GEN – Requirement No. 7 – Annual report Ethics/DP AB on ethics issues
- Deliverable D8.8 – GEN – Requirement No. 8 – Annual report Ethics/DP AB on ethics issues
- Deliverable 8.9 -GEN – Requirement No. 9 – Annual report Ethics/DP AB on ethics issues
- Deliverable 8.10 – GEN – Requirement No. 10 – MOOD ethics management plan
- Deliverable 8.11 – POPD – Requirement No. 11 – Safeguard privacy-by-design/value sensitive web mining
- Deliverable 8.12 – Legal requirements concerning intellectual property law and data ownership frameworks
Overall Progress on WP Deliverables
WP1 Deliverables
4/5
80%
WP2 Deliverables
2/3
66%
WP3 Deliverables
4/4
100%
WP4 Deliverables
1/6
15%
WP5 Deliverables
1/3
33%
WP6 Deliverables
3/6
50%
WP7 Deliverables
9/11
72%
WP8 Deliverables
11/12
83%